JG
REGN icon

Jefferies Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Jefferies Group’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-22,300
Closed -$15.6M – 1797
2022
Q1 		$15.6M Buy
+22,300
New +$14.1M 0.1% 164
2020
Q2 		– Sell
-10,800
Closed -$5.27M – 1918
2020
Q1 		$5.27M Sell
10,800
-1,100
-9% -$454K 0.06% 306
2019
Q4 		$4.47M Buy
11,900
+8,700
+272% +$2.93M 0.03% 570
2019
Q3 		$888K Sell
3,200
-20,800
-87% -$6.16M 0.01% 1582
2019
Q2 		$7.51M Buy
+24,000
New +$7.99M 0.05% 307
2018
Q4 		– Sell
-5,500
Closed -$2.22M – 2487
2018
Q3 		$2.22M Buy
5,500
+5,400
+5,400% +$2.06M 0.01% 923
2018
Q2 		$34K Sell
100
-6,500
-98% -$2.03M ﹤0.01% 2218
2018
Q1 		$2.27M Sell
6,600
-3,500
-35% -$1.22M 0.01% 806
2017
Q4 		$3.8M Buy
10,100
+9,600
+1,920% +$3.89M 0.02% 671
2017
Q3 		$224K Sell
500
-3,800
-88% -$1.81M ﹤0.01% 2022
2017
Q2 		$2.11M Buy
+4,300
New +$1.88M 0.01% 908
2017
Q1 		– Sell
-100
Closed -$37K – 2600
2016
Q4 		$37K Sell
100
-25,500
-100% -$9.7M ﹤0.01% 2100
2016
Q3 		$10.3M Buy
25,600
+21,500
+524% +$8.62M 0.05% 311
2016
Q2 		$1.43M Buy
+4,100
New +$1.58M 0.01% 1013
2015
Q3 		– Sell
-500
Closed -$255K – 2893
2015
Q2 		$255K Buy
+500
New +$244K ﹤0.01% 1857
2013
Q3 		– Sell
-4,200
Closed -$944K – 2148
2013
Q2 		$944K Buy
+4,200
New +$978K 0.01% 806

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Jefferies Group's REGN Position: Q2 2022 in Review

Jefferies Group sold out of Regeneron Pharmaceuticals (REGN) in Q2 2022, closing a stake of 27,236 shares — an estimated $19M sold.

Jefferies Group first reported a position in REGN in Q2 2013 and held it in 31 quarters. The position peaked at $19M in Q1 2022. 1,063 funds tracked by Wall St. Rank hold REGN as of Q2 2022.

  • Jefferies Group reported no remaining Regeneron Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • Jefferies Group sold 27,236 Regeneron Pharmaceuticals shares in Q2 2022, an estimated $19M.
  • Jefferies Group first reported a position in Regeneron Pharmaceuticals in Q2 2013 and held it in 31 quarters.
  • Jefferies Group's Regeneron Pharmaceuticals position peaked at $19M in Q1 2022.
  • 1,063 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2022.

Based on Jefferies Group's 13F filing for Q2 2022, filed 15 Aug 2022.